Promoting Physical Resilience and Cancer Care Equity for Older Adults Diagnosed with Gastrointestinal Malignancy, REACH Study

Inclusion Criteria

• PHASE I: Gastrointestinal Cancer Center (GCC) English-speaking OA age >= 70 and identified caregivers of older adult patients
• PHASE I: Clinical staff and faculty included social workers, physicians, nurse practitioners, physician assistants, oncology nurse navigators, infusion nurses, clinical specialists and nurse educators
• PHASE II PATIENTS: Age >= 65 years and diagnosed with a gastrointestinal cancer, including any of the following: cancers of the esophagus, stomach, pancreas, liver, bile duct, ampulla, colon, rectum, or anus, as well as neuroendocrine tumors are eligible for this study
• PHASE II PATIENTS: Participants must be continuing care at DF/BWCC in order to be eligible for REACH (including Longwood and Chestnut Hill locations)
• PHASE II PATIENTS: Patients who screen pre-frail or frail from the electronic frailty assessment (EFA) (scores of 0.2 – 0.34 or 0.35 – 1, respectively) are eligible for the research study which includes geriatric and pharmacy consult
• PHASE II PATIENTS: For patients scheduled in the Pancreas and Biliary Tumor Center (PBTC), they will be eligible for research approach regardless of EFA frailty score (robust, pre-frail, or frail). At this time, patients must be proficient in English, Spanish, Portuguese, Russian, Arabic, Traditional Chinese, or Haitian Creole to participate
• PHASE II PATIENTS: Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria

• PHASE II PATIENTS: Patients who are < 65 years old at time of consultation appointment with DF/BWCC
• PHASE II PATIENTS: Patients who do not continue care at DF/BWCC beyond a first consult visit
• PHASE II PATIENTS: Patients who do not screen pre-frail or frail from the electronic fitness assessment, except for those patients seen for care in PBTC
• PHASE II PATIENTS: Patients who speak a language other than English, Spanish, Portuguese, Russian, Arabic, Traditional Chinese, or Haitian Creole
• PHASE II PATIENTS: Patients who are not considered appropriate for enrollment due to complex social, medical, or other situation as determined by their primary oncology team
• PHASE II PATIENTS: Participants with psychiatric illness/social situations that would limit compliance with study requirements